Symptoms Of Schizophrenia: Linked To Patterns Of Normal Brain Activity
Posted by Drew | : Brain Phenomenon, Uncategorized
Researchers discover why schizophrenia symptoms vary depending on the individual
A relatively new study offers hope towards learning how certain individuals behave during an episode of psychosis. The study, which appeared in the June 18th issue of The Journal of Neuroscience, discussed the brain activity of healthy individuals compared with participants who ingested the drug “ketamine.” The club drug, and old anesthesia drug, ketamine, is known to induce symptoms of psychosis that mimic psychosis episodes and schizophrenia. The findings in this “ketamine study” help us explain why the symptoms of schizophrenia are completely unique depending on the individual. The results will also help make treatments of psychosis and schizophrenia more personal and uniquely formatted to fit the specific individual needs.
In psychosis, researchers often wonder why one individual may suffer from only odd perceptions, while others are haunted by paranoid-type beliefs that they are being hunted down by the C.I.A., and in other cases, there appears to be only severe disorganization of thoughts. Because of the wide-variety of symptoms, Paul Fletcher, a licensed M.D. at Cambridge University decided to study it.
Paul Fletcher and researchers hypothesized that different symptoms have specific biological links: each of which may disrupt normal cognition and brain function. The researchers were drawn to the fact that individual differences in normal brain activity could determine which cognitive processes are most at risk of being affected by psychosis, schizophrenia, or a drug-induced state.
Schizophrenia is a disease with symptoms that include what are referred to as negative symptoms and positive symptoms. Negative symptoms include: the loss of normal behaviors, reductions in speech, and social withdrawal. Positive symptoms include: hallucinations (auditory, visual), delusions, and disordered thought. Because everyone is unique, each person suffering from the devastating disease of schizophrenia or psychosis could have significantly different symptoms than another person with the disease.
Ketamine, also called “Special K,” is an often-abused analgesic that is able to induce both positive and negative symptoms in individuals. Like psychosis, the side-effects of ketamine vary from individual to individual and are unpredictable. Ketamine is a drug that works by blocking certain receptors in the brain that regulate the neurotransmitter glutamate - also implicated in schizophrenia.
How the study worked
Using MRI imaging, researchers made profiles of individuals either exposed to ketamine or a placebo while the participants did a wide-variety of cognitive tests. The researchers proceeded to evaluate the behaviors of the participants by using medically accepted psychiatric scales. Exactly one month after the evaluation, participants returned to repeat the testing in the opposite condition. Basically, each participant had an M.R.I. taken and was observed after exposure to both ketamine and the placebo. (To clear up any misunderstanding: Each person that had ketamine the first time had the placebo the second time… Each person that had the placebo the first time had ketamine the second time. M.R.I.’s were taken of every participant - both rounds of the study)…
The results of the study: brain activity linked to symptoms
The team of researchers discovered that increased brain activity during some tests with the placebo condition predicted the behaviors when in the psychosis-like ketamine condition. What the researchers found was very interesting! Participants who displayed more frontal and temporal brain activity while “imagining the sounds of voices” in the placebo condition, were very likely to experience strange perceptions during the ketamine condition.
The others, who showed increased activity in the frontal and temporal sections of the brain while trying to complete simple sentences, were much more likely to have disordered thinking while exposed to the ketamine. The brain’s frontal lobe is involved in executive functions such as: planning, making decisions, advanced thinking, and analyzing our environment, while the brain’s temporal lobe is primarily involved in memory, hearing, and speech.
In contrast experiencing positive symptoms, participants who displayed an increased frontal lobe response to a test involving attention while taking a placebo, were increasingly vulnerable to experiencing negative symptoms while observed under the drug ketamine. Also, participants that displayed increased response in a combination of the frontal lobe, thalamus region, and caudate region - (linked brain circuitry that allow us to carry out motor and executive functions — an area often impaired in psychosis and schizophrenia–) - had a tendency to display negative symptoms while under the effects of ketamine.
Groundbreaking research? Maybe not, but it’s a step in the right direction!
This research is a huge step towards heightening our understanding of the mysterious diseases of schizophrenia and psychosis (2 fairly interchangeable terms, with slightly different diagnoses). Now, at least researchers have some form of biological link towards determining and demystifying the unique set of symptoms that are experienced. The researchers also noted the fact that the participants that were under exposure to ketamine were not at risk towards developing any sort of mental disorder. The participants also provided us with further understanding of how certain drugs and certain diseases can induce different states of consciousness in different people.
This study provides us with insight that may allow us to successfully predict psychotic symptoms induced by drugs and disease. A study author, Fletcher said, “This perhaps raises the prospect of early intervention strategies targeted toward schizophrenia patients’ individual patterns of symptom vulnerability.” I completely agree here, this study appears to be slightly groundbreaking, although I feel that researchers are only at the tip of the iceberg. There is a lot of work that still needs to be done in the area of the largely misunderstood psychosis / schizophrenia, but scientists are giving those that suffer a boosted morale and a sense of hope.
Note: The research was supported by the Medical Research Council, The Wellcome Trust, and the Bernard Wolfe Health Neuroscience Fund.
Popularity: 2% [?]


